Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Isavuconazole | hsa00040 | Pentose and glucuronate interconversions | 3.53E-02 | 1 | O60701 | UGDH | More | | Isavuconazole | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Isavuconazole | hsa00071 | Fatty acid degradation | 2.54E-03 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Isavuconazole | hsa00190 | Oxidative phosphorylation | 3.50E-02 | 2 | Q16718, Q13488 | NDUFA5, TCIRG1 | More | | Isavuconazole | hsa00500 | Starch and sucrose metabolism | 2.37E-06 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Isavuconazole | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Isavuconazole | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Isavuconazole | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Isavuconazole | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Isavuconazole | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | | Isavuconazole | hsa00620 | Pyruvate metabolism | 4.20E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Isavuconazole | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.12E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Isavuconazole | hsa00730 | Thiamine metabolism | 6.59E-07 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Isavuconazole | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Isavuconazole | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | | Isavuconazole | hsa00770 | Pantothenate and CoA biosynthesis | 2.27E-02 | 2 | O95498, O95497 | VNN2, VNN1 | More | | Isavuconazole | hsa00970 | Aminoacyl-tRNA biosynthesis | 4.85E-07 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Isavuconazole | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Isavuconazole | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Isavuconazole | hsa01100 | Metabolic pathways | 1.01E-03 | 35 | Q9NR34, P05089, O95455, P21953, P15144, P32320, P22748, P11766, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P42330, Q13093, Q08477, P15907, Q9NY28, P57054, Q9UNP4, Q9BX95, P09960, P37837, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q16718 | MAN1C1, ARG1, TGDS, BCKDHB, ANPEP, CDA, CA4, ADH5, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, AKR1C3, PLA2G7, CYP4F3, ST6GAL1, GALNT8, PIGP, ST3GAL5, SGPP1, LTA4H, TALDO1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, NDUFA5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05089 | ARG1 | Arginase-1 | 0.807 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O95455 | TGDS | dTDP-D-glucose 4,6-dehydratase | -0.716 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | -0.709 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P15144 | ANPEP | Aminopeptidase N | 0.763 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32320 | CDA | Cytidine deaminase | 0.714 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P32320 | CDA | Cytidine deaminase | 0.706 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | -0.857 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06280 | GLA | Alpha-galactosidase A | 0.706 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P06280 | GLA | Alpha-galactosidase A | 0.764 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.919 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.779 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43451 | MGAM | Maltase-glucoamylase | 0.925 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.715 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.709 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.71 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.74 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.734 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | -0.708 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | -0.7 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.793 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.722 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q9NY28 | GALNT8 | Probable polypeptide N-acetylgalactosaminyltransferase 8 | -0.795 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.726 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.713 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | P09960 | LTA4H | Leukotriene A-4 hydrolase | 0.772 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P37837 | TALDO1 | Transaldolase | 0.843 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32321 | DCTD | Deoxycytidylate deaminase | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.899 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.709 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.899 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P46976 | GYG1 | Glycogenin-1 | 0.866 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.783 | P16389 | KCNA2 | Potassium voltage-gated channel subfamily A member 2 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.837 |
| Isavuconazole | hsa01240 | Biosynthesis of cofactors | 2.05E-02 | 2 | P36551, O60701 | CPOX, UGDH | More | | Isavuconazole | hsa03010 | Ribosome | 3.56E-06 | 14 | P62753, P42677, P32969, P40429, P62917, P46776, Q9H0U6, Q07020, P62910, Q02878, P36578, P05386, P62249, P23396 | RPS6, RPS27, RPL9, RPL13A, RPL8, RPL27A, MRPL18, RPL18, RPL32, RPL6, RPL4, RPLP1, RPS16, RPS3 | More | | Isavuconazole | hsa03020 | RNA polymerase | 9.86E-07 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | | Isavuconazole | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Isavuconazole | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Isavuconazole | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Isavuconazole | hsa04024 | cAMP signaling pathway | 1.53E-02 | 4 | P49019, P22694, P20020, P48058 | HCAR3, PRKACB, ATP2B1, GRIA4 | More | | Isavuconazole | hsa04060 | Cytokine-cytokine receptor interaction | 3.57E-03 | 4 | P37173, P78552, O75509, P80075 | TGFBR2, IL13RA1, TNFRSF21, CCL8 | More | | Isavuconazole | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Isavuconazole | hsa04064 | NF-kappa B signaling pathway | 1.14E-03 | 11 | Q13489, O00463, Q13546, P14778, Q9UDY8, Q13077, Q16548, Q8WV28, P24522, P09341, Q9UNE0 | BIRC3, TRAF5, RIPK1, IL1R1, MALT1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1, EDAR | More | | Isavuconazole | hsa04070 | Phosphatidylinositol signaling system | 1.53E-02 | 2 | Q86XP1, Q96DU7 | DGKH, ITPKC | More | | Isavuconazole | hsa04072 | Phospholipase D signaling pathway | 9.70E-03 | 2 | Q92529, Q14344 | SHC3, GNA13 | More | | Isavuconazole | hsa04145 | Phagosome | 2.75E-02 | 4 | Q15080, P14598, P68371, Q13488 | NCF4, NCF1, TUBB2C, TCIRG1 | More | | Isavuconazole | hsa04150 | mTOR signaling pathway | 2.23E-02 | 3 | P42338, Q13322, P49841 | PIK3CB, GRB10, GSK3B | More | | Isavuconazole | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Isavuconazole | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Isavuconazole | hsa04217 | Necroptosis | 1.48E-03 | 6 | P01568, Q13489, Q13546, P08238, O43633, Q08752 | IFNA21, BIRC3, RIPK1, HSP90AB1, CHMP2A, PPID | More | | Isavuconazole | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Isavuconazole | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Isavuconazole | hsa04380 | Osteoclast differentiation | 4.80E-02 | 4 | P06239, P42338, P14778, Q8N149 | LCK, PIK3CB, IL1R1, LILRA2 | More | | Isavuconazole | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Isavuconazole | hsa04612 | Antigen processing and presentation | 1.51E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A | More | | Isavuconazole | hsa04613 | Neutrophil extracellular trap formation | 1.73E-02 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Isavuconazole | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Isavuconazole | hsa04621 | NOD-like receptor signaling pathway | 3.36E-03 | 11 | Q16539, P01568, Q13489, P10599, Q9H1Y0, P43490, O00463, Q13546, P01375, P09341, P12838 | MAPK14, IFNA21, BIRC3, TXN, ATG5, PBEF1, TRAF5, RIPK1, TNF, CXCL1, DEFA4 | More | | Isavuconazole | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Isavuconazole | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | | Isavuconazole | hsa04650 | Natural killer cell mediated cytotoxicity | 1.15E-03 | 9 | P17252, P78314, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | PRKCA, SH3BP2, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Isavuconazole | hsa04657 | IL-17 signaling pathway | 1.38E-03 | 6 | O00463, Q16539, P49841, P09341, P14780, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, TNF | More | | Isavuconazole | hsa04659 | Th17 cell differentiation | 2.08E-03 | 8 | P19174, P06239, P14784, P14778, P84022, Q13485, P08238, P07766 | PLCG1, LCK, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Isavuconazole | hsa04660 | T cell receptor signaling pathway | 1.81E-02 | 8 | O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539, P49841 | RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14, GSK3B | More | | Isavuconazole | hsa04662 | B cell receptor signaling pathway | 4.56E-04 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Isavuconazole | hsa04664 | Fc epsilon RI signaling pathway | 2.47E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Isavuconazole | hsa04713 | Circadian entrainment | 1.69E-02 | 3 | P17252, P48058, P22694 | PRKCA, GRIA4, PRKACB | More | | Isavuconazole | hsa04714 | Thermogenesis | 3.16E-02 | 3 | P22694, P33121, Q16718 | PRKACB, ACSL1, NDUFA5 | More | | Isavuconazole | hsa04721 | Synaptic vesicle cycle | 1.14E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Isavuconazole | hsa04723 | Retrograde endocannabinoid signaling | 1.20E-03 | 4 | P17252, P48058, P22694, Q16718 | PRKCA, GRIA4, PRKACB, NDUFA5 | More | | Isavuconazole | hsa04724 | Glutamatergic synapse | 1.31E-02 | 3 | P48058, P22694, P17252 | GRIA4, PRKACB, PRKCA | More | | Isavuconazole | hsa04726 | Serotonergic synapse | 2.62E-02 | 3 | P22694, P17252, P31645 | PRKACB, PRKCA, SLC6A4 | More | | Isavuconazole | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | | Isavuconazole | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.72E-02 | 3 | P14778, P42338, P24723 | IL1R1, PIK3CB, PRKCH | More | | Isavuconazole | hsa04911 | Insulin secretion | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Isavuconazole | hsa04913 | Ovarian steroidogenesis | 1.28E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Isavuconazole | hsa04918 | Thyroid hormone synthesis | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Isavuconazole | hsa04925 | Aldosterone synthesis and secretion | 9.86E-03 | 3 | P17252, P22694, P20020 | PRKCA, PRKACB, ATP2B1 | More | | Isavuconazole | hsa04929 | GnRH secretion | 3.63E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Isavuconazole | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Isavuconazole | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Isavuconazole | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | | Isavuconazole | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | | Isavuconazole | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | | Isavuconazole | hsa04970 | Salivary secretion | 7.14E-03 | 3 | P22694, P20020, P17252 | PRKACB, ATP2B1, PRKCA | More | | Isavuconazole | hsa04972 | Pancreatic secretion | 1.48E-03 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | | Isavuconazole | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Isavuconazole | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Isavuconazole | hsa04976 | Bile secretion | 3.01E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Isavuconazole | hsa05010 | Alzheimer disease | 7.11E-03 | 9 | O15239, P13073, P18848, O15169, P67870, P05141, P12236, P28070, P43686 | NDUFA1, COX4I1, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4 | More | | Isavuconazole | hsa05012 | Parkinson disease | 2.14E-02 | 7 | O15239, P13073, P05141, P12236, P18848, P28070, P43686 | NDUFA1, COX4I1, SLC25A5, SLC25A6, ATF4, PSMB4, PSMC4 | More | | Isavuconazole | hsa05016 | Huntington disease | 2.46E-05 | 3 | Q9GZM3, P52435, Q9NYC9 | POLR2J2, POLR2J, DNAH9 | More | | Isavuconazole | hsa05017 | Spinocerebellar ataxia | 4.66E-02 | 4 | P28070, P43686, P05141, P12236 | PSMB4, PSMC4, SLC25A5, SLC25A6 | More | | Isavuconazole | hsa05020 | Prion disease | 1.55E-03 | 10 | P46531, O15239, P13073, P18848, P05141, P12236, P28070, P43686, P67870, P51636 | NOTCH1, NDUFA1, COX4I1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, CSNK2B, CAV2 | More | | Isavuconazole | hsa05022 | Pathways of neurodegeneration - multiple diseases | 5.20E-04 | 15 | P67870, O15239, Q16718, P13073, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, O15169, Q08752, P28070, P43686 | CSNK2B, NDUFA1, NDUFA5, COX4I1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, AXIN1, PPID, PSMB4, PSMC4 | More | | Isavuconazole | hsa05031 | Amphetamine addiction | 1.69E-02 | 3 | P48058, P22694, P17252 | GRIA4, PRKACB, PRKCA | More | | Isavuconazole | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Isavuconazole | hsa05100 | Bacterial invasion of epithelial cells | 4.50E-02 | 1 | Q92529 | SHC3 | More | | Isavuconazole | hsa05110 | Vibrio cholerae infection | 3.01E-02 | 2 | P17252, P22694 | PRKCA, PRKACB | More | | Isavuconazole | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.36E-03 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Isavuconazole | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | | Isavuconazole | hsa05140 | Leishmaniasis | 1.77E-03 | 7 | P13612, O75015, P13765, O60603, P01375, P49006, Q16539 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MARCKSL1, MAPK14 | More | | Isavuconazole | hsa05144 | Malaria | 3.30E-02 | 4 | P60033, O60603, P35443, P26718 | CD81, TLR2, THBS4, KLRK1 | More | | Isavuconazole | hsa05146 | Amoebiasis | 5.00E-03 | 6 | P09341, P14778, P27930, P01375, O60603, P05089 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1 | More | | Isavuconazole | hsa05163 | Human cytomegalovirus infection | 3.44E-03 | 9 | P01375, P50151, Q14643, P49841, P14778, P25025, Q16539, P04637, O00463 | TNF, GNG10, ITPR1, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5 | More | | Isavuconazole | hsa05171 | Coronavirus disease - COVID-19 | 1.08E-04 | 13 | P23396, P62753, P62249, P42677, P40429, P36578, Q02878, P62917, P32969, Q07020, P46776, P62910, P05386 | RPS3, RPS6, RPS16, RPS27, RPL13A, RPL4, RPL6, RPL8, RPL9, RPL18, RPL27A, RPL32, RPLP1 | More | | Isavuconazole | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Isavuconazole | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Isavuconazole | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Isavuconazole | hsa05210 | Colorectal cancer | 3.43E-02 | 2 | Q9UKG1, P37173 | APPL1, TGFBR2 | More | | Isavuconazole | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Isavuconazole | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Isavuconazole | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Isavuconazole | hsa05224 | Breast cancer | 4.51E-03 | 7 | P46531, Q9UM47, O15169, P49841, Q92837, P04637, P24522 | NOTCH1, NOTCH3, AXIN1, GSK3B, FRAT1, TP53, GADD45A | More | | Isavuconazole | hsa05225 | Hepatocellular carcinoma | 1.85E-02 | 2 | Q92529, P51531 | SHC3, SMARCA2 | More | | Isavuconazole | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.55E-02 | 5 | O95267, P09693, O60603, Q16539, P01730 | RASGRP1, CD3G, TLR2, MAPK14, CD4 | More | | Isavuconazole | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Isavuconazole | hsa05415 | Diabetic cardiomyopathy | 3.54E-03 | 6 | P17252, P30405, P14598, Q15080, Q16718, P37173 | PRKCA, PPIF, NCF1, NCF4, NDUFA5, TGFBR2 | More | | Isavuconazole | hsa05418 | Fluid shear stress and atherosclerosis | 2.04E-04 | 8 | Q16539, P42338, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, PIK3CB, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | | |